LBA Wealth Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

LBA Wealth Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-35	Closed	-$2K	–	472
2016 Q1	$2K	Hold	35	–	–	﹤0.01%	399
2015 Q4	$4K	Buy	+35	New	+$3.86K	﹤0.01%	362

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

LBA Wealth Management's ANAC Position: Q2 2016 in Review

LBA Wealth Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 35 shares — an estimated $2K sold.

LBA Wealth Management first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $4K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

LBA Wealth Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
LBA Wealth Management sold 35 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2K.
LBA Wealth Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
LBA Wealth Management's ANACOR PHARMACEUTICALS INC COM position peaked at $4K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on LBA Wealth Management's 13F filing for Q2 2016, filed 12 Aug 2016.